Literature DB >> 1253827

Comparative action of fenfluramine on the uptake and release of serotonin and dopamine.

M H Kannengiesser, P F Hunt, J P Raynaud.   

Abstract

The anorectic agent, fenfluramine, proves to be a good inhibitor of serotonin uptake in vitro, in synaptosomes from rat whole brain (IC50 = 8.5 +/- 0.6 X 10(-7) M). After administration in vivo, its inhibitory activity in vitro equals that of chlorimipramine and in contrast to the latter, its effect is of long duration. Fenfluramine is also effective in promoting the release of serotonin from pre-loaded synaptosomes. In comparison, the structurally related compound, amphetamine, has little activity with respect to these serotonin mechanisms. It is, however, active both in inhibiting the uptake of dopamine and in promoting its release, whereas fenfluramine is inactive. The implication of these mechanisms in the serotonin-depleting capacity as well as in the anorectic activity of fenfluramine is discussed.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1253827     DOI: 10.1016/0014-2999(76)90298-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

Review 1.  Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA).

Authors:  J R Docherty
Journal:  Br J Pharmacol       Date:  2008-06       Impact factor: 8.739

2.  Effects of stimulants, anorectics, and related drugs on schedule-controlled behavior.

Authors:  A D Harris; D Snell; H H Loh
Journal:  Psychopharmacology (Berl)       Date:  1978-01-31       Impact factor: 4.530

3.  Mazindol and amphetamine as inhibitors of the uptake and releasers of 3H-dopamine by rat striatal synaptosomes.

Authors:  M O Carruba; G B Picotti; F Zambotti; P Mantegazza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-05       Impact factor: 3.000

4.  Suppression of behavioral activity by norfenfluramine and related drugs in rats is not mediated by serotonin release.

Authors:  C W Callaway; L L Wing; D E Nichols; M A Geyer
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

5.  Increased central 5-hydroxytryptamine receptor mechanisms in rats after chronic neuroleptic treatment.

Authors:  D Dawbarn; S K Long; C J Pycock
Journal:  Br J Pharmacol       Date:  1981-05       Impact factor: 8.739

6.  Blockage of progesterone-induced release of luteinizing hormone and prolactin by d-amphetamine and fenfluramine in rats.

Authors:  A O Donoso
Journal:  Psychopharmacology (Berl)       Date:  1977-12-19       Impact factor: 4.530

7.  Amphetamine analogs have differential effects on DRL 36-s schedule performance.

Authors:  K E Sabol; J B Richards; K Layton; L S Seiden
Journal:  Psychopharmacology (Berl)       Date:  1995-09       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.